TIDMODX

RNS Number : 2538L

Omega Diagnostics Group PLC

11 January 2021

11 January 2021

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Exercise of Options and Total Voting Rights

Omega Diagnostics (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces that it has allotted 31,304 new ordinary shares of 4 pence each in the capital of the Company ("Ordinary Shares") following the exercise of share options under the Company's Sharesave scheme by certain option holders.

Application has been made to the London Stock Exchange for the 31,304 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 15 January 2021.

After Admission, the total number of Ordinary Shares in issue will be 179,980,923 and the total number of voting rights will therefore be 179,980,923. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.The below notification is made in accordance with the requirements of the EU Market Abuse Regulation.

Contacts:

 
 Omega Diagnostics Group PLC                      Tel: 01259 763 030 
 Colin King, Chief Executive                www.omegadiagnostics.com 
 Kieron Harbinson, Group Finance Director 
 
 
 finnCap Ltd                                      Tel: 020 7220 0500 
 Geoff Nash / Teddy Whiley (Corporate 
  Finance) 
 Alice Lane (ECM) 
 
 Walbrook PR Limited                           Tel: 020 7933 8780 or 
                                                omega@walbrookpr.com 
 Paul McManus                                     Mob: 07980 541 893 
 Lianne Cawthorne                                 Mob: 07584 391 303

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVRSFAFSFEFSEIF

(END) Dow Jones Newswires

January 11, 2021 06:00 ET (11:00 GMT)

Grafico Azioni Omega Diagnostics (LSE:ODX)
Storico
Da Mar 2024 a Apr 2024 Clicca qui per i Grafici di Omega Diagnostics
Grafico Azioni Omega Diagnostics (LSE:ODX)
Storico
Da Apr 2023 a Apr 2024 Clicca qui per i Grafici di Omega Diagnostics